03:01 , Sep 1, 2018 |  BioCentury  |  Politics, Policy & Law

A pathway to Biopharma 3.0

As market and social forces continue to tighten around the biopharmaceutical industry, drug companies need to start evolving toward a new business model that both capitalizes on the potential of new technologies and accommodates society’s...
21:30 , Jul 24, 2018 |  BC Innovations  |  Translation in Brief

Interaction analysis

In a collaboration with Merck & Co. Inc. (NYSE:MRK) and SomaLogic Inc., University of Cambridge researchers have identified associations and causal relationships between thousands of genetic variants, plasma proteins and disease states, which could reveal...
00:43 , Jun 29, 2018 |  BC Innovations  |  Product R&D

Highly personal

Pact Pharma Inc. has raised $120 million in venture financing to tackle one of the most complex forms of personalized medicine proposed to date: neoantigen-targeted T cells. Backed by Alphabet Inc.’s GV, the company is...
19:06 , May 18, 2018 |  BC Week In Review  |  Company News

BC Platforms, Google Cloud partner to offer genomics solutions

Genomic data management company BC Platforms (Basel, Switzerland) partnered with Google Cloud from Google Inc.'s parent company Alphabet Inc. (NASDAQ:GOOG) to deliver integrated genomics and clinical data solutions via Google's services to hospitals and industry...
23:43 , May 15, 2018 |  BioCentury  |  Finance

Single Celsius

After identifying its first targets, Third Rock Ventures newco Celsius Therapeutics emerged from stealth with a $65 million series A round to apply single-cell genomics techniques to drug development for autoimmune diseases and cancer. GV,...
16:19 , May 4, 2018 |  BC Week In Review  |  Company News

Gilead, Verily seek to uncover immunological insights from Gilead trials

Gilead Sciences Inc. (NASDAQ:GILD) and the Verily Life Sciences LLC (South San Francisco, Calif.) subsidiary of Google parent company Alphabet Inc. (NASDAQ:GOOG) partnered to identify and characterize immunological and molecular drivers of rheumatoid arthritis, inflammatory...
23:36 , Apr 30, 2018 |  BC Extra  |  Company News

Gilead, Verily seek to uncover immunological insights from Gilead trials

Gilead Sciences Inc. (NASDAQ:GILD) and the Verily Life Sciences LLC (South San Francisco, Calif.) subsidiary of Google parent company Alphabet Inc. (NASDAQ:GOOG) partnered to identify and characterize immunological and molecular drivers of rheumatoid arthritis, inflammatory...
16:43 , Apr 16, 2018 |  BC Extra  |  Tools & Techniques

Google unveils prototype cancer-detecting microscope

Pathology researchers from the Google Inc. unit of Alphabet Inc. (NASDAQ:GOOG) presented early data from artificial intelligence algorithms designed to detect and assess the aggressiveness of cancer, and allowed visitors to test a microscope that...
15:19 , Jan 2, 2018 |  BC Extra  |  Financial News

Bioinformatics company DNAnexus raises $58M

DNAnexus Inc. (Mountain View, Calif.) raised $58 million in an untranched financing led by new investor Foresite Capital. New investor Microsoft Corp. (NASDAQ:MSFT) also participated, as did existing investors GV, TPG Biotech, WuXi NextCode Genomics...
19:09 , Dec 8, 2017 |  BC Week In Review  |  Company News

Google, Verily release open-source machine-learning genomics technology

The Google Brain team and the Verily Life Sciences LLC (South San Francisco, Calif.) subsidiary of Google parent company Alphabet Inc. (NASDAQ:GOOG) announced the open-source release of its DeepVariant machine-learning technology. DeepVariant is designed to...